The Gut-Liver Axis in Pediatric Liver Health and Disease

被引:8
|
作者
Rager, Stephanie L. [1 ,2 ]
Zeng, Melody Y. [1 ,2 ,3 ]
机构
[1] Weill Cornell Med, Gale & Ira Drukier Inst Childrens Hlth, New York, NY 10021 USA
[2] Weill Cornell Med, Dept Pediat, New York, NY 10021 USA
[3] Weill Cornell Med, Immunol & Microbial Pathogenesis Grad Program, New York, NY 10021 USA
关键词
gut microbiota; pediatrics; hepatobiliary disease; biliary atresia; NAFLD; IBD; PRIMARY SCLEROSING CHOLANGITIS; INFLAMMATORY-BOWEL-DISEASE; CHAIN FATTY-ACIDS; CYSTIC-FIBROSIS; OBESE CHILDREN; EARLY-LIFE; MICROBIOTA; IMPACT; ESTABLISHMENT; COLONIZATION;
D O I
10.3390/microorganisms11030597
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
There has been growing interest in the complex host-microbe interactions within the human gut and the role these interactions play in systemic health and disease. As an essential metabolic organ, the liver is intimately coupled to the intestinal microbial environment via the portal venous system. Our understanding of the gut-liver axis comes almost exclusively from studies of adults; the gut-liver axis in children, who have unique physiology and differing gut microbial communities, remains poorly understood. Here, we provide a comprehensive overview of common pediatric hepatobiliary conditions and recent studies exploring the contributions of the gut microbiota to these conditions or changes of the gut microbiota due to these conditions. We examine the current literature regarding the microbial alterations that take place in biliary atresia, pediatric non-alcoholic fatty liver disease, Wilson's disease, cystic fibrosis, inflammatory bowel disease, and viral hepatitis. Finally, we propose potential therapeutic approaches involving modulation of the gut microbiota and the gut-liver axis to mitigate the progression of pediatric liver disease.
引用
收藏
页数:16
相关论文
共 50 条
  • [41] Gut-liver axis and disease infidelity: A subject worth exploring
    Prasenjit Das
    Govind K. Makharia
    [J]. Indian Journal of Gastroenterology, 2014, 33 (6) : 503 - 506
  • [42] Fat, cancer, the gut-liver axis and rare liver diseases
    Berenguer, Marina
    [J]. JHEP REPORTS, 2020, 2 (06)
  • [43] Microbiota and Gut-Liver Axis: Their Influences on Obesity and Obesity-Related Liver Disease
    Vajro, Pietro
    Paolella, Giulia
    Fasano, Alessio
    [J]. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2013, 56 (05): : 461 - 468
  • [44] Gut-liver axis and probiotics: Their role in non-alcoholic fatty liver disease
    Paolella, Giulia
    Mandato, Claudia
    Pierri, Luca
    Poeta, Marco
    Di Stasi, Martina
    Vajro, Pietro
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (42) : 15518 - 15531
  • [45] The gut-liver axis in nonalcoholic fatty liver disease: molecular mechanisms and new targets
    Schneider, Kai Markus
    Trautwein, Christian
    [J]. GASTROENTEROLOGE, 2020, 15 (02): : 112 - 122
  • [46] The Gut-Liver Axis in Nonalcoholic Fatty Liver Disease: Another Pathway to Insulin Resistance?
    Vanni, Ester
    Bugianesi, Elisabetta
    [J]. HEPATOLOGY, 2009, 49 (06) : 1790 - 1792
  • [47] Intestinal Permeability in Non-alcoholic Fatty LIVER Disease: The Gut-liver Axis
    Scarpellini, E.
    Lupo, M.
    Iegri, C.
    Gasbarrini, A.
    De Santis, A.
    Tack, J.
    [J]. REVIEWS ON RECENT CLINICAL TRIALS, 2014, 9 (03) : 141 - 147
  • [48] Probiotics and Gut-Liver Axis: Novel Molecular Mechanism for preventing Alcoholic Liver Disease
    Mandal, Palash
    Patel, Farhin
    Parwani, Kirti
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 352 - 352
  • [49] Gut-liver axis and probiotics: Their role in non-alcoholic fatty liver disease
    Giulia Paolella
    Claudia Mandato
    Luca Pierri
    Marco Poeta
    Martina Di Stasi
    Pietro Vajro
    [J]. World Journal of Gastroenterology, 2014, 20 (42) : 15518 - 15531
  • [50] Gut-liver axis and fibrosis in nonalcoholic fatty liver disease: An input for novel therapies
    Frasinariu, Otilia E.
    Ceccarelli, Sara
    Alisi, Anna
    Moraru, Evelina
    Nobili, Valerio
    [J]. DIGESTIVE AND LIVER DISEASE, 2013, 45 (07) : 543 - 551